Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication

被引：0
|
作者：
Uygun, A.
Kadayifci, A.
Yesilova, Z.
Ates, Y.
Safali, M.
Ilgan, S.
Bagci, S.
Dagalp, K.
机构：
[1] Gulhane Mil Med Acad, Div Gastroenterol, Ankara, Turkey
[2] Univ Gaziantep, Div Gastroenterol, Gaziantep, Turkey
[3] Gulhane Mil Med Acad, Dept Pathol, Ankara, Turkey
[4] Gulhane Mil Med Acad, Dept Nucl Med, Ankara, Turkey
来源：
HELICOBACTER | 2007年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：429 / 430
页数：2
相关论文
共 50 条
  • [1] Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : 2213 - 2215
  • [2] Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies
    Chan, FKL
    Sung, JJY
    Suen, R
    Wu, JCY
    Ling, TKW
    Chung, SCS
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (01) : 91 - 95
  • [3] Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori
    Duggan, A
    Williamson, R
    [J]. GUT, 1998, 42 (04) : 596 - 597
  • [4] Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori -: Reply
    Malfertheiner, P
    Mégraud, F
    O'Morain, C
    [J]. GUT, 1998, 42 (04) : 597 - 597
  • [5] Ranitidine bismuth citrate (RBC)-based triple therapies for recurring Helicobacter pylori (Hp) eradication
    Yakovenko, A
    Grigoriev, P
    Yakovenko, E
    Abazova, F
    Poliakov, A
    Agafonova, N
    Pryanishnikova, A
    Chtcherbina, E
    Gulyaev, P
    Gorodinskaya, V
    Avanyan, N
    [J]. GUT, 1999, 45 : A117 - A118
  • [6] Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy
    Rinaldi, V
    Zullo, A
    De Francesco, V
    Hassan, C
    Winn, S
    Stoppino, V
    Faleo, D
    Attili, AF
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (02) : 163 - 168
  • [7] Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients
    Köksal, AS
    Parlak, E
    Filik, L
    Yolcu, ÖF
    Ödemis, B
    Ülker, A
    Sasmaz, N
    Özden, A
    Sahin, B
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (04) : 637 - 642
  • [8] Lansoprazole or ranitidine bismuth citrate based triple therapies for Helicobacter pylori eradication: Results of an open randomized study
    Spadaccini, A
    DeFanis, C
    Sciampa, G
    Pantaleone, U
    DiVirgilio, M
    Pizzicannella, G
    [J]. GUT, 1997, 41 : A212 - A212
  • [9] Lansoprazole or ranitidine bismuth citrate based triple therapies for Helicobacter pylori eradication: Results of an open randomized study
    Spadaccini, A
    DeFanis, C
    Sciampa, G
    Pantaleone, U
    DiVirgilio, M
    Pizzicannella, G
    [J]. GUT, 1997, 41 : A105 - A105
  • [10] Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection
    Mönkemüller, KE
    Hirschowitz, BI
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (05) : 661 - 665
12345